First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation.

Blood
Rizwan RomeeJeffrey S Miller

Abstract

New therapies for patients with hematologic malignancies who relapse after allogeneic hematopoietic cell transplantation (allo-HCT) are needed. Interleukin 15 (IL-15) is a cytokine that stimulates CD8+ T-cell and natural killer (NK) cell antitumor responses, and we hypothesized this cytokine may augment antileukemia/antilymphoma immunity in vivo. To test this, we performed a first-in-human multicenter phase 1 trial of the IL-15 superagonist complex ALT-803 in patients who relapsed >60 days after allo-HCT. ALT-803 was administered to 33 patients via the IV or subcutaneous (SQ) routes once weekly for 4 doses (dose levels of 1, 3, 6, and 10 μg/kg). ALT-803 was well tolerated, and no dose-limiting toxicities or treatment-emergent graft-versus-host disease requiring systemic therapy was observed in this clinical setting. Adverse events following IV administration included constitutional symptoms temporally related to increased serum IL-6 and interferon-γ. To mitigate these effects, the SQ route was tested. SQ delivery resulted in self-limited injection site rashes infiltrated with lymphocytes without acute constitutional symptoms. Pharmacokinetic analysis revealed prolonged (>96 hour) serum concentrations following SQ, but not IV, i...Continue Reading

References

Nov 8, 2001·Trends in Immunology·M A CooperM A Caligiuri
Mar 3, 2004·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Eduardus F M PosthumaJ H Frederik Falkenburg
Jun 25, 2005·Blood·Sameek RoychowdhuryMichael A Caligiuri
Jun 8, 2006·Proceedings of the National Academy of Sciences of the United States of America·Mark P RubinsteinJonathan Sprent
Jul 21, 2006·Leukemia·B G M DurieUNKNOWN International Myeloma Working Group
Jan 24, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce D ChesonUNKNOWN International Harmonization Project on Lymphoma
Jul 25, 2008·Blood·Michael A Caligiuri
Dec 2, 2011·The New England Journal of Medicine·John KorethRobert J Soiffer
Aug 31, 2012·The New England Journal of Medicine·Jeffrey M VenstromKatharine C Hsu
May 6, 2014·Cancer Immunology Research·Ines Pires da SilvaNina Bhardwaj
Nov 19, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kevin C ConlonThomas A Waldmann
Sep 29, 2015·Current Opinion in Organ Transplantation·Melissa M Berrien-ElliottTodd A Fehniger
Oct 2, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maximillian RosarioTodd A Fehniger
Jul 15, 2016·The New England Journal of Medicine·Matthew S DavidsUNKNOWN Leukemia and Lymphoma Society Blood Cancer Research Partnership
Sep 23, 2016·Science Translational Medicine·Rizwan RomeeTodd A Fehniger
Oct 4, 2017·The Journal of Clinical Investigation·Julia A WagnerTodd A Fehniger

❮ Previous
Next ❯

Citations

Sep 12, 2018·Molecular Imaging·Mariya ShapovalovaAaron M LeBeau
Oct 31, 2018·Proceedings of the National Academy of Sciences of the United States of America·Meili ZhangThomas A Waldmann
Oct 27, 2018·Seminars in Immunopathology·Michelle L SaetersmoenKarl-Johan Malmberg
Jan 11, 2019·Cancers·Alexander David Barrow, Marco Colonna
Feb 8, 2019·Journal of Leukocyte Biology·Daniel R RamR Keith Reeves
May 24, 2019·Leukemia & Lymphoma·Sameem M Abedin, Leonidas C Platanias
Mar 12, 2020·Expert Opinion on Biological Therapy·Karin M KnudsonSofia R Gameiro
Feb 28, 2020·Science Translational Medicine·Graham Ogg
Feb 28, 2020·Science Translational Medicine·Madison R MackBrian S Kim
Apr 19, 2020·Journal for Immunotherapy of Cancer·Karin M KnudsonSofia R Gameiro
Apr 11, 2020·Journal for Immunotherapy of Cancer·Carla V Rothlin, Sourav Ghosh
Apr 4, 2020·American Society of Clinical Oncology Educational Book·Isabella Claudia GlitzaKim Margolin
Apr 26, 2020·The Journal of Immunology : Official Journal of the American Association of Immunologists·Lindsey G HawkeMark L Ormiston
Dec 19, 2018·The Journal of Experimental Medicine·Michael D BernWayne M Yokoyama
Dec 21, 2018·Frontiers in Immunology·Cordelia ManickamR Keith Reeves
May 3, 2020·Expert Opinion on Drug Delivery·Chalet Tan, Thomas A Waldmann
Mar 7, 2020·Frontiers in Immunology·Cai ZhangChongdeng Shi
Aug 9, 2020·Molecular Cancer·Song-Yang WuZhi-Ming Shao
Mar 21, 2019·Blood Advances·Martin FelicesVeronika Bachanova
Feb 26, 2019·Frontiers in Oncology·Gaurav NayyarMitchell S Cairo
Dec 26, 2018·Expert Opinion on Biological Therapy·Kejian WangHuang Zhu
Jul 26, 2019·Cancers·Ziqing ChenAndreas Lundqvist
Oct 19, 2019·Journal of Clinical Medicine·Simona SivoriDaniela Pende
Dec 6, 2019·Frontiers in Oncology·Connor Sweeney, Paresh Vyas
Oct 17, 2019·International Journal of Molecular Sciences·Paola FisicaroCarolina Boni
Sep 6, 2019·Journal of Oncology·Paolo Bernasconi, Oscar Borsani
Mar 3, 2020·Frontiers in Immunology·Susanne H C BaumeisterRizwan Romee
Jan 8, 2020·Nature Reviews. Drug Discovery·Noriko ShimasakiDario Campana
Jun 9, 2020·Frontiers in Cellular and Infection Microbiology·Stephen PierceTodd Bradley
Jun 2, 2020·Frontiers in Immunology·Aline PfefferleKarl-Johan Malmberg
Nov 11, 2018·British Journal of Cancer·Pedro BerraondoIgnacio Melero
Dec 14, 2018·International Journal of Molecular Sciences·Hanley N Abramson
Mar 23, 2019·Journal for Immunotherapy of Cancer·Karin M KnudsonSofia R Gameiro
May 22, 2019·The Journal of Immunology : Official Journal of the American Association of Immunologists·Todd A Fehniger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.